Dr. Azar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3945 E Paradise Falls Dr
Tucson, AZ 85712Phone+1 502-689-7030Fax+1 520-395-9796
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1986 - 1987
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1983 - 1986
Albert Einstein College of MedicineClass of 1983
Certifications & Licensure
AZ State Medical License 1988 - 2025
OR State Medical License 2015 - 2025
WA State Medical License 2015 - 2019
CO State Medical License 1996 - 2013
ME State Medical License Active through 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsLong-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.Priya Rastogi, Gong Tang, Saima Hassan, Charles E Geyer Jr, Catherine A Azar
Breast Cancer Research and Treatment. 2023-06-01 - 263 citationsLapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trialAndré Robidoux, Gong Tang, Priya Rastogi, Charles E. Geyer, Catherine A. Azar
The Lancet. Oncology. 2013-11-01 - 105 citationsDefinitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 TrialSandra M. Swain, Gong Tang, Charles E. Geyer, Priya Rastogi, James N. Atkins
Journal of Clinical Oncology. 2013-09-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
